Suppr超能文献

一种使用羟氯喹筛查患者多焦点视网膜电图的新方法。

A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.

作者信息

Chang Wellington H, Katz Bradley J, Warner Judith E A, Vitale Albert T, Creel Donnell, Digre Kathleen B

机构信息

John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.

出版信息

Retina. 2008 Nov-Dec;28(10):1478-86. doi: 10.1097/IAE.0b013e318181445b.

Abstract

PURPOSE

To evaluate retinal function in patients on hydroxychloroquine using multifocal electroretinography.

METHODS

A retrospective chart review was performed for 23 patients (46 eyes) on hydroxychloroquine therapy and referred for multifocal electroretinogram (mfERG) testing. Duration of treatment, daily hydroxychloroquine dose, visual acuity, fundus examination, color vision testing, Amsler grid testing, visual field examination, and fluorescein angiography results were obtained when available. Multifocal electroretinogram response amplitudes were calculated for the central and paracentral regions and compared with previously published normal values. The central and paracentral regions of the mfERG color difference plot, which assigns colors to localized areas of the mfERG based on deviation from normal, were assessed using a novel Color Difference Plot Scoring System which relies on the color pattern observed within each region.

RESULTS

Ninety-two regions were assessed for response amplitudes, 31 of which showed a depressed response amplitude. Of the 17 eyes which had at least one region with a depressed response amplitude, clinical examination findings were relatively benign. Color difference plot scoring showed strong agreement with response amplitude, with a Color Difference Plot Scoring System score of 2 or 3 showing 93.55% sensitivity and 60% specificity for a depressed response amplitude. Interrater reliability of the scoring system as measured by Kendall's W coefficient of concordance was 0.6484 (P < 0.00001).

CONCLUSION

The mfERG appears to be able to detect decreased retinal function in hydroxychloroquine patients with normal clinical examinations, and may be useful in identifying patients that require close monitoring for the development of clinically relevant toxicity. The Color Difference Plot Scoring System may be used as a tool to aid in the interpretation of results of the mfERG in the clinic setting.

摘要

目的

使用多焦视网膜电图评估服用羟氯喹的患者的视网膜功能。

方法

对23例接受羟氯喹治疗并转诊进行多焦视网膜电图(mfERG)检测的患者(46只眼)进行回顾性病历审查。如有可用信息,获取治疗持续时间、每日羟氯喹剂量、视力、眼底检查、色觉测试、阿姆斯勒方格表测试、视野检查和荧光素血管造影结果。计算中央和旁中央区域的多焦视网膜电图反应振幅,并与先前公布的正常值进行比较。基于与正常情况的偏差为mfERG的局部区域分配颜色的mfERG色差图的中央和旁中央区域,使用一种依赖于在每个区域内观察到的颜色模式的新型色差图评分系统进行评估。

结果

对92个区域的反应振幅进行了评估,其中31个区域显示反应振幅降低。在至少有一个区域反应振幅降低的17只眼中,临床检查结果相对良性。色差图评分与反应振幅显示出高度一致性,色差图评分系统得分为2或3时,对反应振幅降低的敏感性为93.55%,特异性为60%。通过肯德尔和谐系数W测量的评分系统的评分者间信度为0.6484(P < 0.00001)。

结论

mfERG似乎能够在临床检查正常的羟氯喹患者中检测到视网膜功能下降,并且可能有助于识别需要密切监测以发现临床相关毒性的患者。色差图评分系统可作为一种工具,辅助临床环境中mfERG结果的解读。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验